Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCODER study of intensive versus standard Compound Danshen dripping pills in refractory angina with incomplete revascularization
ChiCTR2000032384Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Compound Danshen in angina pectoris and coronary arteriosclerosis (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Change in total exercise time from baseline to week 6. Started May 2020; status: recruiting.
02
Drugs
Compound Danshen
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2000032384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032384.